1. Home
  2. ZLAB vs ITW Comparison

ZLAB vs ITW Comparison

Compare ZLAB & ITW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ITW
  • Stock Information
  • Founded
  • ZLAB 2013
  • ITW 1912
  • Country
  • ZLAB Cayman Islands
  • ITW United States
  • Employees
  • ZLAB N/A
  • ITW N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ITW Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • ITW Industrials
  • Exchange
  • ZLAB Nasdaq
  • ITW Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • ITW 67.7B
  • IPO Year
  • ZLAB 2017
  • ITW N/A
  • Fundamental
  • Price
  • ZLAB $32.00
  • ITW $239.55
  • Analyst Decision
  • ZLAB Buy
  • ITW Hold
  • Analyst Count
  • ZLAB 4
  • ITW 10
  • Target Price
  • ZLAB $47.37
  • ITW $260.40
  • AVG Volume (30 Days)
  • ZLAB 1.7M
  • ITW 1.4M
  • Earning Date
  • ZLAB 05-08-2025
  • ITW 04-30-2025
  • Dividend Yield
  • ZLAB N/A
  • ITW 2.50%
  • EPS Growth
  • ZLAB N/A
  • ITW 20.23
  • EPS
  • ZLAB N/A
  • ITW 11.71
  • Revenue
  • ZLAB $398,988,000.00
  • ITW $15,898,000,000.00
  • Revenue This Year
  • ZLAB $45.57
  • ITW N/A
  • Revenue Next Year
  • ZLAB $47.91
  • ITW $3.47
  • P/E Ratio
  • ZLAB N/A
  • ITW $20.45
  • Revenue Growth
  • ZLAB 49.59
  • ITW N/A
  • 52 Week Low
  • ZLAB $15.65
  • ITW $214.66
  • 52 Week High
  • ZLAB $39.77
  • ITW $279.13
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.83
  • ITW 49.89
  • Support Level
  • ZLAB $28.34
  • ITW $224.90
  • Resistance Level
  • ZLAB $34.59
  • ITW $244.27
  • Average True Range (ATR)
  • ZLAB 2.12
  • ITW 8.31
  • MACD
  • ZLAB 0.40
  • ITW 1.89
  • Stochastic Oscillator
  • ZLAB 74.98
  • ITW 84.06

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ITW Illinois Tool Works Inc.

Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test & measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers & fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.

Share on Social Networks: